Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis
Angong Niuhuang Pill (ANP) is a well-known patented Chinese medicine which is used for hundreds of years for treating the central nervous system diseases. Atherosclerosis is a poly-aetiological chronic inflammatory vascular disease. Preventing inflammation is fundamental for treating atherosclerosis...
Saved in:
Main Authors: | Qinghong Fan (Author), Yujuan Liu (Author), Jiaoyu Rao (Author), Zhe Zhang (Author), Wei Xiao (Author), Tao Zhu (Author), Xiaomeng Chai (Author), Kaihe Ye (Author), Na Ning (Author), Zhen Yin (Author), Yushuang Chai (Author), Yimin Xu (Author), Ruirui Lan (Author), A Verkhratsky (Author), Hong Nie (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angong Niuhuang Pill ameliorates cerebral ischemia/reperfusion injury in mice partly by restoring gut microbiota dysbiosis
by: Han Zhang, et al.
Published: (2022) -
Comprehensive chemical profiling of volatile constituents of Angong Niuhuang Pill in vitro and in vivo based on gas chromatography coupled with mass spectrometry
by: Yue Jiang, et al.
Published: (2022) -
Neuroprotective Effects and Hepatorenal Toxicity of Angong Niuhuang Wan Against Ischemia-Reperfusion Brain Injury in Rats
by: Bun Tsoi, et al.
Published: (2019) -
Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4
by: Bo-Tong Liu, et al.
Published: (2024) -
Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation
by: Hansen Chen, et al.
Published: (2022)